COMPANY
Genetivision Corporation
We offer DNA preparation services for any type of construct, vector, drug selection, or size. We offer a wide range of transgenic services, including P-element insertions, site-specific insertion using the PhiC31 system, MiMIC/RMCE events, and CRISPR gene targeting. From company website Source · Oct 13, 2026
Funding and NIH signals
- NIH award NIH awarded $984K (SBIR Phase II 5R44GM161181-02, continuation, notice Jun 26, 2026). NIH RePORTER 5R44GM161181-02 (Jun 26, 2026)
Evidence (1 event)
- Jun 26, 2026 · NIH RePORTER 5R44GM161181-02
Organization: GENETIVISION CORPORATION; City/State: Stafford, TX; Project number: 5R44GM161181-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-06-26; FY total cost (award amount): 984472; Administering IC: National Institute of General Medical Sciences; Project title: A Precisely Controllable Loss-of-Function Mutation Collection in Drosophila; Organization type: Domestic For-Profits
- Jun 26, 2026 · NIH RePORTER 5R44GM161181-02
Timeline
- Grant Government grant — SBIR: $984,472 (annual award, as published), announced Jun 26, 2026. Agency: NIH/NIGMS. Source: government award database. source ↗
- Grant Government grant — SBIR: $1.06M (annual award, as published), announced Jul 14, 2025. Agency: NIH/NIGMS. Source: government award database. source ↗
Funding
NIH awards 10
- NIH award 5R44GM148146-02 FY2023: $837,115 awarded for that fiscal year; activity R44 (SBIR); PI TAN, YING; recipient as written: GENETIVISION CORPORATION, Stafford, TX. A Conditional Loss-of-Function Mutation Collec source ↗
- NIH award 3R44GM148146-01S1 FY2023: $93,763 awarded for that fiscal year; activity R44 (SBIR); PI TAN, YING; recipient as written: GENETIVISION CORPORATION, Stafford, TX. A Conditional Loss-of-Function Mutation Colle source ↗
- NIH award 1R44GM148146-01 FY2022: $893,628 awarded for that fiscal year; activity R44 (SBIR); PI TAN, YING; recipient as written: GENETIVISION CORPORATION, Stafford, TX. A Conditional Loss-of-Function Mutation Collec source ↗
- NIH award 3R44GM112248-03S1 FY2018: $47,976 awarded for that fiscal year; activity R44 (SBIR); PI FA, MING; recipient as written: GENETIVISION CORPORATION, Stafford, TX. Toward a Complete Set of Germline Null and Mod source ↗
- NIH award 5R44GM112248-03 FY2018: $749,865 awarded for that fiscal year; activity R44 (SBIR); PI FA, MING; recipient as written: GENETIVISION CORPORATION, Stafford, TX. Toward a Complete Set of Germline Null and Modi source ↗
- NIH award 2R44GM112248-02 FY2017: $749,865 awarded for that fiscal year; activity R44 (SBIR); PI FA, MING; recipient as written: GENETIVISION CORPORATION, Stafford, TX. Toward a Complete Set of Germline Null and Modi source ↗
- NIH award 5R44GM099188-03 FY2014: $834,702 awarded for that fiscal year; activity R44 (SBIR); PI FA, MING; recipient as written: GENETIVISION CORPORATION, Stafford, TX. A New Tool Kit for Whole-Genome Mapping and Com source ↗
- NIH award 1R43GM112248-01 FY2014: $219,679 awarded for that fiscal year; activity R43 (SBIR); PI FA, MING; recipient as written: GENETIVISION CORPORATION, Stafford, TX. Toward a Complete Set of Germline Null and Modi source ↗
- NIH award 2R44GM099188-02 FY2013: $1,458,991 awarded for that fiscal year; activity R44 (SBIR); PI FA, MING; recipient as written: GENETIVISION CORPORATION, Stafford, TX. A New Tool Kit for Whole-Genome Mapping and C source ↗
- NIH award 1R43GM099188-01A1 FY2012: $197,666 awarded for that fiscal year; activity R43 (SBIR); PI FA, MING; recipient as written: GENETIVISION CORPORATION, Stafford, TX. A New Tool Kit for Whole-Genome Mapping and C source ↗